Healthcare
Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals stock analysis and opportunity scoring
$784.85
↓ -0.58%
Regeneron Pharmaceuticals (REGN) at a glance
Regeneron Pharmaceuticals (REGN) is a publicly traded company in the Healthcare - Biotechnology sector tracked by MKD Intelligence.
REGN last traded at $834.04 as of 2026-09-21.
MKD Intelligence assigns REGN a composite opportunity score of 48 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for REGN is 40 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$852.03
Low
$774.11
Period
Sep 18 - Aug 21 (20d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Sep 21
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.